Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically.

We have shown that a murine CD4+ PPD-reactive T lymphocyte clone was weakly cytotoxic towards the syngeneic tumour B16 melanoma and MC6A fibrosarcoma which had been coated with PPD using a monoclonal antibody-PPD heteroconjugate. Cell-free supernatants produced by PPD-stimulated T lymphocyte clones were however highly cytostatic for the two tumour targets when assayed over 48-72 h. In this study we have demonstrated good titres of tumour necrosis factor (TNF) and interferon-gamma (IFN-gamma) in the supernatants, which accounted for their observed cytostatic activity on the tumour targets. The high level of cytostasis seen with the B16 melanoma using the supernatants could be attributed to their sensitivity to the cytostatic activity of IFN-gamma; the lower levels of cytostasis seen with the IFN-gamma-resistant MC6A target was the result of IFN-gamma increasing the sensitivity of this target to TNF. Antibodies to IFN-gamma were able to neutralize the majority of the cytostatic activity of the supernatants on both targets, consistent with the role demonstrated for this lymphokine.
AuthorsM G Wing, A M Montgomery, C Harley, P J Lachmann
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 82 Issue 2 Pg. 208-13 (Nov 1990) ISSN: 0009-9104 [Print] ENGLAND
PMID2122929 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD4
  • Tuberculin
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Animals
  • Antigens, CD4 (immunology)
  • Clone Cells
  • Cytotoxicity, Immunologic
  • Drug Synergism
  • Fibrosarcoma (pathology)
  • Interferon-gamma (biosynthesis, physiology)
  • Melanoma, Experimental (pathology)
  • Mice
  • T-Lymphocytes (immunology, metabolism)
  • Tuberculin (immunology)
  • Tumor Cells, Cultured (pathology)
  • Tumor Necrosis Factor-alpha (biosynthesis, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: